Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Rubin KevinChief Financial Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $23K 118 sh | Sep 28, 2026 |
| 7 | Lie SeanChief Technology Officer |  CBRSCerebras Systems Inc.Derivative conversion · 10b5-1 plan | C | — 120.0K sh | Sep 28, 2026 traded Sep 25, 2026 |
| 7 | Golechha DipakEVP, Chief Financial Officer |  PANWPalo Alto Networks IncOpen-market sale · 10b5-1 plan | SELL | $2.08M 5,301 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 6 | Lie SeanChief Technology Officer | CBRSCerebras Systems Inc. Gift · 10b5-1 plan | G | — 36.0K sh | Sep 28, 2026 traded Sep 25, 2026 |
| 5 | Duffey Gregory ADirector |  FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/Grant or award | A | $3,195 51 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 5 | Bhalla Narinder PalChief Medical Officer |  LXEOLexeo Therapeutics, Inc.Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Tamayo Louis EdwardChief Financial Officer | LXEOLexeo Therapeutics, Inc. Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Keeler Anne BDirector |  FMBMF&M BANK CORPGrant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Snook Gregory IDirector | FRAFFRANKLIN FINANCIAL SERVICES CORP /PA/ Grant or award | A | $6,453 103 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America |  JXNJackson Financial Inc.Grant or award | A | — 19 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 25 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 18 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 53 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Otero Jose ManuelChief Operating Officer | LXEOLexeo Therapeutics, Inc. Grant or award | A | — 54.8K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Malady KyleEVP and Group CEO-VZ Business |  VZVERIZON COMMUNICATIONS INCGrant or award | A | $1,739 129 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Raub ChristopherEVP JFI; CEO PPM America | JXNJackson Financial Inc. Grant or award | A | — 2 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Dorrance Bennett JRDirector |  CPBCAMPBELL'S CoGrant or award | A | — 2,204 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 5 | Wray Peter HDirector | FMBMF&M BANK CORP Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Hutman Hannah W.Director | FMBMF&M BANK CORP Grant or award | A | $6,180 153 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 5 | Radakovich Lynn VojvodichDirector |  DELLDell Technologies Inc.Grant or award | A | — 419 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $350K 900 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $451K 6,000 sh | Sep 28, 2026 traded Sep 28, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $842K 2,160 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Option exercise · 10b5-1 plan | M | — 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $355K 900 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $9,332 3,333 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Golechha DipakEVP, Chief Financial Officer | PANWPalo Alto Networks Inc Open-market sale · 10b5-1 plan | SELL | $866K 2,200 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Eisen Anthony MathewDirector | XYZBlock, Inc. Open-market sale · 10b5-1 plan | SELL | $447K 6,000 sh | Sep 28, 2026 traded Sep 24, 2026 |
| 4 | Eisen Anthony MathewDirector | XYZBlock, Inc. Open-market sale · 10b5-1 plan | SELL | $461K 6,000 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 3 | Lie SeanChief Technology Officer | CBRSCerebras Systems Inc. Option exercise · 10b5-1 plan | M | — 3,125 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 3 | Song EstherSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $15K 147 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 2 | Townsend Richard NolanDirector, Chief Executive Officer | LXEOLexeo Therapeutics, Inc. Grant or award | A | — 145.5K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 1 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Derivative conversion · 10b5-1 plan | C | $1.78M 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 1 | Navratil TomasCHIEF DEVELOPMENT OFFICER |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $168K 1,083 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 1 | Iglesias Sanchez OscarDirector |  CDROCodere Online Luxembourg, S.A.Open-market sale · 10b5-1 plan | SELL | $4,647 460 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Mancini AnthonySee Remarks |  RVMDRevolution Medicines, Inc.Option exercise · 10b5-1 plan | M | — 3,121 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Derivative conversion · 10b5-1 plan | C | — 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 0 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner | DUOLDuolingo, Inc. Derivative conversion · 10b5-1 plan | C | — 46.7K sh | Sep 28, 2026 traded Sep 24, 2026 |
| 0 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Option exercise · 10b5-1 plan | M | $105K 3,121 sh | Sep 28, 2026 traded Sep 25, 2026 |
| 0 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $9,332 3,333 sh | Sep 28, 2026 traded Sep 24, 2026 |
